Skip to content

QNRX

Quoin Pharmaceuticals, Ltd.

NASDAQ · Healthcare · Biotechnology · US

$7.26
−7.75%
Ask drillr
8
Insider buys (3m)
0
Insider sells (3m)
$454.9K
Net value (3m)
+60.8%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 1, 2026Culverwell Anthony James · directorPurchase3,073$6.10
Sep 1, 2026Carter Denise P. · director, officer: Chief Operating OfficerPurchase20,490$4.88
Sep 1, 2026Carter Denise P. · director, officer: Chief Operating OfficerPurchase10,245$6.10
Sep 1, 2026Myers Michael · director, officer: Chief Executive OfficerPurchase20,490$4.88
Sep 1, 2026Myers Michael · director, officer: Chief Executive OfficerPurchase10,245$6.10
Sep 1, 2026Lawlor Sally Bridget · officer: Chief Financial OfficerPurchase10,244$4.88
Sep 1, 2026Lawlor Sally Bridget · officer: Chief Financial OfficerPurchase5,122$6.10
Sep 1, 2026Culverwell Anthony James · directorPurchase6,146$4.88
Aug 28, 2026Culverwell Anthony James · directorA-Award31,352$5.15
Aug 28, 2026LANGER DENNIS · directorA-Award34,534$5.15
Feb 6, 2026Leong Natalie Ee Mun · directorA-Award12,211$7.37
Feb 6, 2026SEMBER MICHAEL T · directorA-Award8,141$7.37
Feb 6, 2026LANGER DENNIS · directorA-Award21,709$7.37
Feb 6, 2026Carter Denise P. · director, officer: Chief Operating OfficerA-Award318,750$7.37
Feb 6, 2026Myers Michael · director, officer: Chief Executive OfficerA-Award318,750$7.37
Feb 6, 2026Culverwell Anthony James · directorA-Award21,709$7.37
Feb 6, 2026Cooper Joseph Patrick · directorA-Award8,141$7.37
Feb 6, 2026Lawlor Sally Bridget · officer: Chief Financial OfficerA-Award85,250$7.37
Dec 3, 2025Lawlor Sally Bridget · officer: Chief Financial OfficerA-Award10,330$19
Oct 15, 2025LANGER DENNIS · directorPurchase15,152$8.49
Aug 25, 2025LANGER DENNIS · directorA-Award13,682$9.07
Aug 25, 2025Culverwell Anthony James · directorA-Award13,682$9.07
Aug 25, 2025Leong Natalie Ee Mun · directorA-Award4,105$9.07
Jun 13, 2025Myers Michael · director, officer: Chief Executive OfficerA-Award42,857$9.07
Jun 13, 2025Carter Denise P. · director, officer: Chief Operating OfficerA-Award42,857$9.07
Jun 3, 2025Culverwell Anthony James · directorA-Award7,760$9.07
Jun 2, 2025Cooper Joseph Patrick · directorA-Award7,760$9.07
Jun 2, 2025LANGER DENNIS · directorA-Award7,760$9.07
Jun 2, 2025SEMBER MICHAEL T · directorA-Award7,760$9.07
Jun 2, 2025Leong Natalie Ee Mun · directorA-Award7,760$9.07
Institutional positioning

13F filings over the trailing two quarters

New 6Increased 6Reduced 5Sold out 21
FilerActionSharesFiled
IKARIAN CAPITAL, LLCUnchanged211,538May 15, 2026
DAUNTLESS INVESTMENT GROUP, LLCNew Position196,592May 14, 2026
SUMMITTX CAPITAL, L.P.Increased100,300May 15, 2026
VELAN CAPITAL INVESTMENT MANAGEMENT LPNew Position84,849May 15, 2026
WOODLINE PARTNERS LPUnchanged79,582May 15, 2026
MILLENNIUM MANAGEMENT LLCIncreased76,247May 15, 2026
ABRDN PLCUnchanged75,000Apr 29, 2026
SOLEUS CAPITAL MANAGEMENT, L.P.Increased72,730May 14, 2026
CENTIVA CAPITAL, LPIncreased60,000May 14, 2026
BOOTHBAY FUND MANAGEMENT, LLCUnchanged59,838May 15, 2026
STONEPINE CAPITAL MANAGEMENT, LLCReduced53,460May 14, 2026
AIGH CAPITAL MANAGEMENT LLCIncreased51,000Apr 30, 2026
CITADEL ADVISORS LLCNew Position32,519May 15, 2026
BIRCHVIEW CAPITAL, LPNew Position20,000May 15, 2026
MORGAN STANLEYReduced4,000May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 1, 2026